Quince Therapeutics, Inc. (QNCX) — Long-term Investment Intensity
Quince Therapeutics, Inc. (QNCX) has a Long-term Investment Intensity of 0.3% as of March 2026. Long-term investments of $78.00K represent 0.3% of total assets of $26.62 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check QNCX cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Quince Therapeutics, Inc. Long-term Investment Intensity (2019–2025)
This chart shows how Quince Therapeutics, Inc.'s Long-term Investment Intensity has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the intensity stands at 0.3%, reflecting long-term investments of $78.00K against total assets of $26.62 Million USD. Explore Quince Therapeutics, Inc. (QNCX) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Quince Therapeutics, Inc. (2019–2025)
The table below presents the year-by-year Long-term Investment Intensity for Quince Therapeutics, Inc. from 2019 to 2025, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see how much is Quince Therapeutics, Inc. worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 0.1% | $78.00K | $93.52 Million | ▲ +0.0 pp |
| 2024 | 0.1% | $78.00K | $114.48 Million | ▲ +0.0 pp |
| 2023 | 0.0% | $78.00K | $180.20 Million | ▼ -3.4 pp |
| 2022 | 3.4% | $3.58 Million | $103.91 Million | ▼ -11.5 pp |
| 2021 | 15.0% | $19.93 Million | $133.23 Million | ▼ -11.7 pp |
| 2020 | 26.6% | $50.46 Million | $189.47 Million | ▲ +13.2 pp |
| 2019 | 13.5% | $16.76 Million | $124.37 Million | — |